世界のカプセル内視鏡市場の規模、シェア、トレンド分析レポート – 業界の概要と2032年までの予測

カプセル内視鏡市場分析

カプセル内視鏡市場は、改良された画像技術とワイヤレス システムの導入により、大きな進歩を遂げてきました。最近の技術革新には、より鮮明な画像とより優れた診断機能を実現する、高度な発光ダイオード (LED) を備えた高解像度ビデオ カプセルが含まれます。リアルタイムのワイヤレス データ伝送の開発により、モニタリング プロセスが大幅に強化され、医師は患者を遠隔で診断できるようになりました。さらに、カプセルの小型化により、カプセルの快適性と飲み込みやすさが向上し、患者のコンプライアンスが向上しました。

人工知能(AI) と機械学習も、画像分析を自動化することで市場を変革しています。AI アルゴリズムは、腫瘍や潰瘍などの異常を迅速に検出できるため、診断の速度と精度が向上します。さらに、クラウドベースのプラットフォームとの統合により、医療提供者は患者データを安全かつリアルタイムで保存、共有、分析できるようになります。

これらの技術が進歩するにつれ、世界のカプセル内視鏡市場は力強い成長を遂げています。非侵襲性診断ツールの需要増加と、消化器疾患の罹患率と認知度の高まりが、市場の拡大を牽引しています。イメージング、AI、患者中心のソリューションの革新により、市場は今後も成長を続けると予想されます。

カプセル内視鏡市場規模

世界のカプセル内視鏡市場規模は、2024年に5億6,941万米ドルと評価され、2025年から2032年の予測期間中に8.6%のCAGRで成長し、2032年までに11億171万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

カプセル内視鏡市場の動向

「ワイヤレスカプセル内視鏡技術の進歩」

カプセル内視鏡市場の成長を牽引する特定のトレンドの 1 つは、ワイヤレス カプセル技術の継続的な進歩です。これらの技術革新により、画像解像度の向上、バッテリー寿命の延長、データ伝送の強化が可能になり、患者にとってより効果的で快適な処置が可能になります。たとえば、メドトロニックによる PillCam C3 の導入により、高解像度ビデオによる胃腸画像診断が革命的に改善され、小腸のより鮮明な画像化が可能になりました。この進歩により、カプセル内視鏡はクローン病や胃腸出血などの症状の診断に好まれる選択肢となりました。これらの技術の進歩により侵襲的処置の必要性が減るため、市場の成長とアクセス性に大きく貢献しています。

レポートの範囲とカプセル内視鏡市場のセグメンテーション

カプセル内視鏡市場の定義

Capsule endoscopy is a minimally invasive procedure used to examine the inside of the digestive tract, particularly the small intestine. A patient swallows a small, pill-sized capsule containing a camera, light source, and transmitter. As the capsule moves through the digestive system, it captures images and sends them to an external device worn by the patient. This procedure helps diagnose conditions such as Crohn's disease, gastrointestinal bleeding, celiac disease, and tumors. Capsule endoscopy is an effective, non-invasive alternative to traditional endoscopy, providing detailed images of areas that are difficult to reach with standard scopes.

Capsule Endoscopy Market Dynamics

Drivers

• Increased Prevalence of Gastrointestinal Disorders

The growing prevalence of gastrointestinal disorders, including Crohn's disease, colorectal cancer, and gastrointestinal (GI) bleeding, is significantly driving the demand for capsule endoscopes. For instance, the incidence of colorectal cancer is rising globally, with over 1.9 million new cases reported in 2020, according to the World Health Organization. Capsule endoscopy provides a non-invasive, effective means of diagnosing and monitoring these conditions, particularly in hard-to-reach areas such as the small intestine. Early detection through capsule endoscopy enables timely intervention and treatment, improving patient outcomes. As the number of GI disorder cases rises, healthcare systems are increasingly relying on capsule endoscopes for better diagnosis and disease management.

• Integration with Telemedicine

The integration of capsule endoscopy with telemedicine is a key driver for the market’s growth. This combination allows healthcare providers to remotely monitor and diagnose gastrointestinal conditions, increasing accessibility in rural and underserved regions. For instance, companies such as Given Imaging have developed systems that enable the transmission of capsule endoscopy data directly to healthcare professionals, allowing for remote review and diagnosis. This remote capability eliminates the need for patients to travel long distances to specialized centers, improving convenience and reducing healthcare costs. As telemedicine continues to expand globally, the demand for capsule endoscopes is expected to grow, making this integration a significant market driver.

Opportunities

• Integration with Telemedicine

The integration of capsule endoscopy with telemedicine creates significant opportunities in the market by enabling remote diagnostics. This combination allows healthcare providers to monitor and analyze capsule endoscopy data from a distance, offering patients in rural or underserved areas access to advanced diagnostic tools without the need for travel. For instance, in regions such as Sub-Saharan Africa, where access to specialist care is limited, telemedicine enables gastroenterologists to review capsule endoscopy images remotely, facilitating timely diagnoses. As telehealth infrastructure improves globally, this opportunity is expected to expand the reach of capsule endoscopy, driving market growth and increasing adoption in remote and economically disadvantaged regions.

• Advancements in Imaging and Data Analysis

Improvements in imaging technology, such as high-resolution video and AI-based data analysis, are creating significant opportunities in the capsule endoscopy market. Enhanced imaging capabilities allow for clearer, more detailed visualization of the gastrointestinal tract, making it easier to detect conditions such as tumors, bleeding, or ulcers. AI-powered analysis further accelerates diagnosis by automating image interpretation, reducing human error, and enabling faster decision-making. For instance, companies such as Medtronic have incorporated AI algorithms in their capsule endoscopes, enhancing the speed and accuracy of diagnosis. These innovations are expected to drive growth, as healthcare providers seek advanced tools to improve patient outcomes and operational efficiency.

Restraints/Challenges

• High Price of Capsule Endoscopy

The high cost of capsule endoscopy devices and associated procedures presents a significant challenge for the market. The initial investment in equipment, along with the expenses related to its maintenance and consumables, limits its adoption in hospitals and healthcare facilities, particularly in developing regions or those with budget constraints. This financial burden can prevent widespread implementation and make it difficult for smaller healthcare providers to offer this advanced diagnostic tool. In addition, the cost factor contributes to limited insurance coverage, further restricting access for patients. As a result, the overall growth and expansion of the capsule endoscopy market are hindered by these financial barriers.   

• Limited Battery Life

Limited battery life in capsule endoscopes is a significant restraint in the market, as it directly impacts the duration and comprehensiveness of the examination. The batteries used in these devices are typically designed to last for a few hours, which can be insufficient for thoroughly assessing patients with complex gastrointestinal issues. This limitation restricts the ability to examine larger or more intricate sections of the digestive tract, potentially leading to incomplete diagnoses. As a result, capsule endoscopy may not be suitable for all patients, limiting its widespread adoption. The need for frequent recharging or replacement further adds to operational challenges, hindering overall market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Capsule Endoscopy Market Scope

The market is segmented on the basis of product, component, type, application, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Small Bowel Capsule
• Colon Capsule
• Esophageal Capsule

 Component

• Camera Capsule
• Workstation
• Data Recorder

 Type

• Wireless Capsule Endoscopy
• Receiver Capsule Endoscopy
• Others

 Application

• Intestine Disease
• Crohn’s Disease
• Gastrointestinal Bleeding
• Tumours
• Others

End Users

• Hospitals
• Diagnostic Laboratories
• Ambulatory Surgery Centres

Capsule Endoscopy Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, component, type, application, and end users as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

North America is expected dominate the capsule endoscopy market due to the rise in the incidence of GI disorders and colorectal cancer. Furthermore, the developed healthcare infrastructure will further boost the growth of the capsule endoscopy treatment market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the capsule endoscopy treatment market due to the rise in the patient awareness levels. Moreover, the enhancing of healthcare infrastructure and disposable income is further anticipated to propel the growth of the capsule endoscopy treatment market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Capsule Endoscopy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Capsule Endoscopy Market Leaders Operating in the Market Are:

• Boston Scientific Corporation (U.S.)
• CapsoCam Plus (U.S.)
• ConMed Corporation (U.S.)
• Cook Medical (U.S.)
• The Guidant Group (U.S.)
• INTROMEDIC (South Korea)
• JINSHAN Science & Technology (China)
• Medtronic (Ireland)
• Olympus Corporation (Japan)
• RF Co., Ltd. (South Korea)
• Fujifilm Holdings Corporation (Japan)
• Check-Cap (Israel)
• Accu-Read, Inc. (U.S.)
• Interscope (U.S.)

Latest Developments in Capsule Endoscopy Market

• In August 2022, Medtronic launched the GI Genius, a colorectal cancer endoscopy module in India. This advanced system enhances colonoscopy procedures by providing improved visualization through artificial intelligence (AI). By offering real-time data, it empowers healthcare professionals to identify and treat colorectal cancer more efficiently, promoting early detection and improved patient outcomes
• メドトロニックは2021年11月、遠隔内視鏡治療用に設計されたPillCam機器のFDA承認を取得しました。PillCam SB3は最先端の画像技術とAmazonの物流ネットワークを組み合わせ、自宅での検査を容易にします。このイノベーションにより、患者は快適な環境で迅速かつ正確な結果を得ることができ、高い診断精度を維持しながら対面での診察の必要性が減ります。
• 2021年9月、メドトロニックの子会社であるギブン・イメージング社は、次世代カプセル内視鏡装置であるピルカムSB4を発表しました。この装置は、高度な画像機能を提供し、胃腸疾患の診断とモニタリングを改善するように設計されています。合理化されたワークフローにより、診断の効率と精度が向上し、医療提供者はより良いケアを提供し、より効果的に疾患をモニタリングできるようになります。
• 富士フイルムホールディングス株式会社は、2021年5月に、胃腸疾患の診断とモニタリングのためのカプセル内視鏡技術を搭載したELUXEO内視鏡システムをリリースしました。このシステムは、胃腸疾患の検出と管理を改善し、より優れた視覚化とより正確な診断機能を提供し、医療従事者が患者の消化器系の健康状態を正確に評価できるようにすることを目指しています。
• 2020年2月、メドトロニックはアマゾンと提携し、カプセル内視鏡「ピルカム ジーニアス」の宅配サービスを開始しました。この提携は、患者が自宅で内視鏡機器を受け取れるようにすることで、世界的なアクセス性を高め、患者の快適性を向上させることを目的としています。この提携により、プロセスを簡素化し、高度な診断ツールの範囲を拡大することで、患者体験が向上します。
• 2020年3月、ジェイビル社の子会社であるRFシステムラボは、高度な画像機能とコンパクトなデザインを誇るVJ-3カプセル内視鏡を発売しました。VJ-3は、胃腸検査の診断精度と効率を向上させるように設計されています。フォームファクタが小さいため、飲み込みやすく、患者の快適性を高めながら、正確な診断のための高品質の画像を保証します。
• 2020年1月、カプセル内視鏡検査の強化を目的とした人工知能（AI）技術を評価するための新たな臨床試験が開始されました。このAIは、医療専門家が消化管の各部分を徹底的に検査するのを支援することで、磁気制御内視鏡検査の品質を向上させるように設計されています。この技術は、診断の精度と患者ケアの向上を約束します。

SKU-50221